Literature DB >> 30006159

Piperlongumine (piplartine) as a lead compound for anticancer agents - Synthesis and properties of analogues: A mini-review.

Kamil Piska1, Agnieszka Gunia-Krzyżak2, Paulina Koczurkiewicz3, Katarzyna Wójcik-Pszczoła1, Elżbieta Pękala1.   

Abstract

Piperlongumine, also known as piplartine, is an amide alkaloid of Piper longum L. (long piper), a medical plant known from Ayurvedic medicine. Although was discovered well over fifty years ago, its pharmacological properties have been uncovered in the past decade. In particular, piperlongumine has been most extensively studied as a potential anticancer agent. Piperlongumine has exhibited cytotoxicity against a broad spectrum of human cancer cell lines, as well as demonstrated antitumor activity in rodents. Piperlongumine has also been found to be a proapoptotic, anti-invasive, antiangiogenic agent and synergize with modern chemotherapeutic agents. Because of its clinical potential, several studies were undertaken to obtain piperlongumine analogues, which have exhibited more potent activity or more appropriate drug-like parameters. In this review, the synthesis of piperlongumine analogues and piperlongumine-based hybrid compounds, as well as their anticancer properties and the molecular basis for their activity are explored. General structure-activity relationship conclusions are drawn and directions for the future research are indicated.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ayurveda; Chemotherapy; Natural product compounds; Piperlongumine; Piplartine; SAR

Mesh:

Substances:

Year:  2018        PMID: 30006159     DOI: 10.1016/j.ejmech.2018.06.057

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  21 in total

Review 1.  Endophytic Penicillium species and their agricultural, biotechnological, and pharmaceutical applications.

Authors:  Rufin Marie Kouipou Toghueo; Fabrice Fekam Boyom
Journal:  3 Biotech       Date:  2020-02-08       Impact factor: 2.406

2.  Antileishmanial activity evaluation of a natural amide and its synthetic analogs against Leishmania (V.) braziliensis: an integrated approach in vitro and in silico.

Authors:  Minelly A da Silva; Harold H Fokoue; Saara N Fialho; Ana Paula de A Dos Santos; Norton R D L P Rossi; Aurileya de J Gouveia; Amália S Ferreira; Guilherme M Passarini; Ana F G Garay; Jorge J Alfonso; Andreimar M Soares; Fernando B Zanchi; Massuo J Kato; Carolina B G Teles; Christian C Kuehn
Journal:  Parasitol Res       Date:  2021-05-08       Impact factor: 2.289

3.  Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway.

Authors:  Di Chen; Xinyue Wei; Ke Yang; Xinyue Liu; Yujin Song; Futing Bai; Yi Jiang; Yuhang Guo; Rajiv Kumar Jha
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

4.  Synthesis and Spectroscopic Analysis of Piperine- and Piperlongumine-Inspired Natural Product Scaffolds and Their Molecular Docking with IL-1β and NF-κB Proteins.

Authors:  Gabriel Zazeri; Ana Paula R Povinelli; Cécile S Le Duff; Bridget Tang; Marinonio L Cornelio; Alan M Jones
Journal:  Molecules       Date:  2020-06-19       Impact factor: 4.411

5.  Inhibition of ERKs/Akt-Mediated c-Fos Expression Is Required for Piperlongumine-Induced Cyclin D1 Downregulation and Tumor Suppression in Colorectal Cancer Cells.

Authors:  Feng Gao; Li Zhou; Ming Li; Wenbin Liu; Shuting Yang; Wei Li
Journal:  Onco Targets Ther       Date:  2020-06-15       Impact factor: 4.147

6.  Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells.

Authors:  Li Zhou; Ming Li; Xinyou Yu; Feng Gao; Wei Li
Journal:  Int J Biol Sci       Date:  2019-03-01       Impact factor: 6.580

7.  Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials.

Authors:  Eunice Ego Mgbeahuruike; Milla Stålnacke; Heikki Vuorela; Yvonne Holm
Journal:  Antibiotics (Basel)       Date:  2019-05-04

Review 8.  The redox-senescence axis and its therapeutic targeting.

Authors:  Natalie Yl Ngoi; Angeline Qx Liew; Stephen J F Chong; Matthew S Davids; Marie-Veronique Clement; Shazib Pervaiz
Journal:  Redox Biol       Date:  2021-06-05       Impact factor: 11.799

9.  XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death.

Authors:  Diego Muñoz; Martina Brucoli; Silvia Zecchini; Adrian Sandoval-Hernandez; Gonzalo Arboleda; Fabian Lopez-Vallejo; Wilman Delgado; Matteo Giovarelli; Marco Coazzoli; Elisabetta Catalani; Clara De Palma; Cristiana Perrotta; Luis Cuca; Emilio Clementi; Davide Cervia
Journal:  Cancers (Basel)       Date:  2019-09-09       Impact factor: 6.639

10.  Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.

Authors:  Ding-Fang Zhang; Zhi-Chun Yang; Jian-Qiang Chen; Xiang-Xiang Jin; Yin-da Qiu; Xiao-Jing Chen; Hong-Yi Shi; Zhi-Guo Liu; Min-Shan Wang; Guang Liang; Xiao-Hui Zheng
Journal:  BMC Complement Med Ther       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.